Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

PHVS
Pharvaris N.V.
stock NASDAQ

Market Open
Sep 8, 2026 10:48:44 AM EDT
39.72USD+12.695%(+4.47)2,697,011
34.48Bid   39.89Ask   5.41Spread
Pre-market
Sep 8, 2026 9:29:30 AM EDT
41.00USD+16.312%(+5.75)197,503
After-hours
Sep 4, 2026 4:00:30 PM EDT
35.25USD-0.028%(-0.01)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 22, 2021
08:10AM EST  Pharvaris Announces Changes to its Board of Directors   GlobeNewswire Inc
Nov 10, 2021
08:19AM EST  Pharvaris Q3 2021 Cash And Cash Equivalents   Benzinga
08:10AM EST  Pharvaris Reports Third Quarter 2021 Financial Results and   GlobeNewswire Inc
Sep 3, 2021
08:00AM EDT  Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today announced that management will participate in the following three upcoming investor conferences in September:   GlobeNewswire Inc
Jul 30, 2021
08:09AM EDT  Pharvaris Q2 EPS (0.94), Up From   Benzinga
08:00AM EDT  Pharvaris Reports Second Quarter 2021 Financial Results and   GlobeNewswire Inc
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 9, 2021
06:10PM EDT  Pharvaris Presents Clinical Data on Oral PHA121 Supporting the   GlobeNewswire Inc
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 7, 2021
07:41AM EDT  The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend   Benzinga
Jul 2, 2021
07:38AM EDT  The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures   Benzinga
Jul 1, 2021
07:08AM EDT  Pharvaris to Present PHA121 Clinical Data for Oral Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021   Benzinga
07:00AM EDT  Pharvaris to Present PHA121 Clinical Data for Oral Treatment of   GlobeNewswire Inc
Jun 23, 2021
07:35AM EDT  The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway   Benzinga
Jun 11, 2021
08:00AM EDT  Pharvaris Announces Annual Meeting of Shareholders   GlobeNewswire Inc
Jun 4, 2021
03:45AM EDT  Pharvaris Presents Pharmacokinetic and Pharmacodynamic Data for   GlobeNewswire Inc
May 26, 2021
08:12AM EDT  Pharvaris Q1 EPS (0.66); Cash And Equivalents Of 238.3M For Quarter Ended Mar. 31   Benzinga
08:00AM EDT  Pharvaris Reports First Quarter 2021 Financial Results and   GlobeNewswire Inc
May 19, 2021
07:30AM EDT  The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics   Benzinga
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 12, 2021
07:00AM EDT  -- Industry veteran with deep commercial experience further strengthens leadership team as company advances development of multiple oral products for HAE patients   GlobeNewswire Inc
Apr 29, 2021
05:07PM EDT  Pharvaris Cash, Cash Equivalents 98.6M As Of Dec. 31, 2020, FY20 Loss 26M   Benzinga
04:53PM EDT  Pharvaris Says Had Cash And Equivalents Of 98.6M   Benzinga
Apr 21, 2021
08:01AM EDT  Pharvaris Announces FDA Acceptance Of IND Application For Prophylactic Treatment Of HAE Using PHVS416   Benzinga
08:00AM EDT  Pharvaris Announces FDA Acceptance of IND Application for   GlobeNewswire Inc
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Mar 4, 2021
08:00AM EST  Pharvaris to Participate in BioCapital Europe   GlobeNewswire Inc
Mar 2, 2021
01:33PM EST  B of A Securities Initiates Coverage On Pharvaris with Neutral Rating, Announces Price Target of $41   Benzinga
11:11AM EST  Oppenheimer Initiates Coverage On Pharvaris with Outperform Rating, Announces Price Target of $48   Benzinga
10:02AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2021   Benzinga
07:58AM EST  Morgan Stanley Maintains Overweight on Pharvaris, Announces $51 Price Target   Benzinga
07:44AM EST  SVB Leerink Initiates Coverage On Pharvaris with Outperform Rating, Announces Price Target of $50   Benzinga
Feb 27, 2021
09:04PM EST  The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings   Benzinga
Feb 26, 2021
08:09AM EST  Pharvaris Reports First Patient Dosed In RAPIDe-1 Phase 2 Trial Of PHVS416 For On-Demand Treatment Of Hereditary Angioedema   Benzinga
08:00AM EST  Pharvaris Doses First Patient in RAPIDe-1, a Phase 2 Study   GlobeNewswire Inc
Feb 23, 2021
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
Feb 19, 2021
10:06AM EST  Pharvaris Says Presents Pharmacodynamic Activity Of Oral PHA121, Under Development For Treatment Of HAE, At AAAAI Annual Meeting   Benzinga
10:00AM EST  Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under   GlobeNewswire Inc
Feb 9, 2021
04:05PM EST  Pharvaris Announces Closing of Initial Public Offering   GlobeNewswire Inc
Feb 5, 2021
12:00PM EST  Pharvaris Shares Open For Trade At $25; IPO Priced At $20/Share   Benzinga
10:21AM EST  Pharvaris Shares Will Open For Quote At 11 a.m. EST, Expected To Open For Trade After 11:10 a.m. EST; IPO Priced At $20/Share   Benzinga
Feb 4, 2021
08:08PM EST  Pharvaris Announces Pricing of Upsized Initial Public Offering   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC